Laparoscopic splenectomy with interferon therapy in 100 hepatitis-C-virus-cirrhotic patients with hypersplenism and thrombocytopenia

Tomohiko Akahoshi, Morimasa Tomikawa, Hirofumi Kawanaka, Norihiro Furusyo, Nao Kinjo, Norifumi Tsutsumi, Yoshihiro Nagao, Jun Hayashi, Makoto Hashizume, Yoshihiko Maehara

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Background and Aim: We intended to determine whether laparoscopic splenectomy (Lap-Sp) contributes to treatment with interferon therapy in hepatitis C virus (HCV)-cirrhotic patients with thrombocytopenia caused by hypersplenism. Methods: From December 2004 to August 2008, 100 cirrhotic patients (54 men and 46 women) underwent Lap-Sp for a clinical application of interferon therapy. All the patients were Child-Pugh class A or B with thrombocytopenia (average platelet count, 56×103/mm3). The HCV genotype was type 1 in 80 patients and type 2 in 20 patients. Results: Pure laparoscopic or hand-assisted laparoscopy was performed in 78 and 22 patients, respectively, without mortality. Conversion to open surgery was not required in any of the patients. The platelet counts improved (mean platelet count 172×103/mm3 1month after surgery) and interferon (IFN) therapy was started in 97 patients. In this study period, 36 patients obtained a sustained virologic response. Eight patients discontinued IFN therapy because of depression, neutropenia or other reasons. Conclusions: Lap-Sp permits most patients with HCV cirrhosis and hypersplenism to receive sufficient IFN therapy. Therefore, Lap-Sp can become a strong supportive surgery for cirrhotic patients who require antiviral therapy.

Original languageEnglish
Pages (from-to)286-290
Number of pages5
JournalJournal of Gastroenterology and Hepatology (Australia)
Volume27
Issue number2
DOIs
Publication statusPublished - Feb 2012

Fingerprint

Hypersplenism
Splenectomy
Hepacivirus
Thrombocytopenia
Interferons
Therapeutics
Platelet Count
Hand-Assisted Laparoscopy
Conversion to Open Surgery
Neutropenia
Antiviral Agents

All Science Journal Classification (ASJC) codes

  • Hepatology
  • Gastroenterology

Cite this

Laparoscopic splenectomy with interferon therapy in 100 hepatitis-C-virus-cirrhotic patients with hypersplenism and thrombocytopenia. / Akahoshi, Tomohiko; Tomikawa, Morimasa; Kawanaka, Hirofumi; Furusyo, Norihiro; Kinjo, Nao; Tsutsumi, Norifumi; Nagao, Yoshihiro; Hayashi, Jun; Hashizume, Makoto; Maehara, Yoshihiko.

In: Journal of Gastroenterology and Hepatology (Australia), Vol. 27, No. 2, 02.2012, p. 286-290.

Research output: Contribution to journalArticle

Akahoshi, Tomohiko ; Tomikawa, Morimasa ; Kawanaka, Hirofumi ; Furusyo, Norihiro ; Kinjo, Nao ; Tsutsumi, Norifumi ; Nagao, Yoshihiro ; Hayashi, Jun ; Hashizume, Makoto ; Maehara, Yoshihiko. / Laparoscopic splenectomy with interferon therapy in 100 hepatitis-C-virus-cirrhotic patients with hypersplenism and thrombocytopenia. In: Journal of Gastroenterology and Hepatology (Australia). 2012 ; Vol. 27, No. 2. pp. 286-290.
@article{b5aa770c9f724f50a25f8bb9e612ae59,
title = "Laparoscopic splenectomy with interferon therapy in 100 hepatitis-C-virus-cirrhotic patients with hypersplenism and thrombocytopenia",
abstract = "Background and Aim: We intended to determine whether laparoscopic splenectomy (Lap-Sp) contributes to treatment with interferon therapy in hepatitis C virus (HCV)-cirrhotic patients with thrombocytopenia caused by hypersplenism. Methods: From December 2004 to August 2008, 100 cirrhotic patients (54 men and 46 women) underwent Lap-Sp for a clinical application of interferon therapy. All the patients were Child-Pugh class A or B with thrombocytopenia (average platelet count, 56×103/mm3). The HCV genotype was type 1 in 80 patients and type 2 in 20 patients. Results: Pure laparoscopic or hand-assisted laparoscopy was performed in 78 and 22 patients, respectively, without mortality. Conversion to open surgery was not required in any of the patients. The platelet counts improved (mean platelet count 172×103/mm3 1month after surgery) and interferon (IFN) therapy was started in 97 patients. In this study period, 36 patients obtained a sustained virologic response. Eight patients discontinued IFN therapy because of depression, neutropenia or other reasons. Conclusions: Lap-Sp permits most patients with HCV cirrhosis and hypersplenism to receive sufficient IFN therapy. Therefore, Lap-Sp can become a strong supportive surgery for cirrhotic patients who require antiviral therapy.",
author = "Tomohiko Akahoshi and Morimasa Tomikawa and Hirofumi Kawanaka and Norihiro Furusyo and Nao Kinjo and Norifumi Tsutsumi and Yoshihiro Nagao and Jun Hayashi and Makoto Hashizume and Yoshihiko Maehara",
year = "2012",
month = "2",
doi = "10.1111/j.1440-1746.2011.06870.x",
language = "English",
volume = "27",
pages = "286--290",
journal = "Journal of Gastroenterology and Hepatology (Australia)",
issn = "0815-9319",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Laparoscopic splenectomy with interferon therapy in 100 hepatitis-C-virus-cirrhotic patients with hypersplenism and thrombocytopenia

AU - Akahoshi, Tomohiko

AU - Tomikawa, Morimasa

AU - Kawanaka, Hirofumi

AU - Furusyo, Norihiro

AU - Kinjo, Nao

AU - Tsutsumi, Norifumi

AU - Nagao, Yoshihiro

AU - Hayashi, Jun

AU - Hashizume, Makoto

AU - Maehara, Yoshihiko

PY - 2012/2

Y1 - 2012/2

N2 - Background and Aim: We intended to determine whether laparoscopic splenectomy (Lap-Sp) contributes to treatment with interferon therapy in hepatitis C virus (HCV)-cirrhotic patients with thrombocytopenia caused by hypersplenism. Methods: From December 2004 to August 2008, 100 cirrhotic patients (54 men and 46 women) underwent Lap-Sp for a clinical application of interferon therapy. All the patients were Child-Pugh class A or B with thrombocytopenia (average platelet count, 56×103/mm3). The HCV genotype was type 1 in 80 patients and type 2 in 20 patients. Results: Pure laparoscopic or hand-assisted laparoscopy was performed in 78 and 22 patients, respectively, without mortality. Conversion to open surgery was not required in any of the patients. The platelet counts improved (mean platelet count 172×103/mm3 1month after surgery) and interferon (IFN) therapy was started in 97 patients. In this study period, 36 patients obtained a sustained virologic response. Eight patients discontinued IFN therapy because of depression, neutropenia or other reasons. Conclusions: Lap-Sp permits most patients with HCV cirrhosis and hypersplenism to receive sufficient IFN therapy. Therefore, Lap-Sp can become a strong supportive surgery for cirrhotic patients who require antiviral therapy.

AB - Background and Aim: We intended to determine whether laparoscopic splenectomy (Lap-Sp) contributes to treatment with interferon therapy in hepatitis C virus (HCV)-cirrhotic patients with thrombocytopenia caused by hypersplenism. Methods: From December 2004 to August 2008, 100 cirrhotic patients (54 men and 46 women) underwent Lap-Sp for a clinical application of interferon therapy. All the patients were Child-Pugh class A or B with thrombocytopenia (average platelet count, 56×103/mm3). The HCV genotype was type 1 in 80 patients and type 2 in 20 patients. Results: Pure laparoscopic or hand-assisted laparoscopy was performed in 78 and 22 patients, respectively, without mortality. Conversion to open surgery was not required in any of the patients. The platelet counts improved (mean platelet count 172×103/mm3 1month after surgery) and interferon (IFN) therapy was started in 97 patients. In this study period, 36 patients obtained a sustained virologic response. Eight patients discontinued IFN therapy because of depression, neutropenia or other reasons. Conclusions: Lap-Sp permits most patients with HCV cirrhosis and hypersplenism to receive sufficient IFN therapy. Therefore, Lap-Sp can become a strong supportive surgery for cirrhotic patients who require antiviral therapy.

UR - http://www.scopus.com/inward/record.url?scp=84856193748&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84856193748&partnerID=8YFLogxK

U2 - 10.1111/j.1440-1746.2011.06870.x

DO - 10.1111/j.1440-1746.2011.06870.x

M3 - Article

C2 - 21793908

AN - SCOPUS:84856193748

VL - 27

SP - 286

EP - 290

JO - Journal of Gastroenterology and Hepatology (Australia)

JF - Journal of Gastroenterology and Hepatology (Australia)

SN - 0815-9319

IS - 2

ER -